Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07611903
NA

HFNC Versus Microstream Advance Nasal Cannula for Oxygenation During ERCP

Sponsor: Kocaeli University

View on ClinicalTrials.gov

Summary

Endoscopic retrograde cholangiopancreatography (ERCP) procedures are commonly performed under deep sedation and are associated with a risk of hypoxemia, particularly in prone or semi-prone positions. High-flow nasal cannula (HFNC) therapy may improve oxygenation by delivering heated and humidified oxygen at high flow rates, while the Microstream Advance nasal cannula provides simultaneous nasal oxygen delivery and oral oxygen insufflation. This prospective randomized study aims to compare the effectiveness of HFNC and Microstream Advance nasal cannula in maintaining oxygenation during ERCP procedures. Patients undergoing ERCP will be randomized into two groups receiving either HFNC or Microstream Advance nasal cannula oxygen support during sedation. The primary outcomes are the incidence of desaturation and oxygen reserve index (ORi) measurements during the procedure. Secondary outcomes include time to achieve target ORi levels, respiratory complications, and procedure-related adverse events.

Key Details

Gender

All

Age Range

18 Years - 84 Years

Study Type

INTERVENTIONAL

Enrollment

74

Start Date

2026-06-29

Completion Date

2026-12-30

Last Updated

2026-05-28

Healthy Volunteers

No

Interventions

DEVICE

High-flow nasal canula

Heated and humidified high-flow oxygen therapy delivered through a nasal cannula during ERCP under sedation

DEVICE

Microstream advance nasal cannula

Oxygen support delivered through the Microstream Advance nasal cannula during ERCP under sedation.